Cargando…

Advances in Lung Cancer Therapy

Detalles Bibliográficos
Autor principal:	Galetta, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216240/ https://www.ncbi.nlm.nih.gov/pubmed/37345008 http://dx.doi.org/10.3390/cancers15102671

Ejemplares similares

Promising Therapy in Lung Cancer: Spotlight on Aurora Kinases
por: Galetta, Domenico, et al.
Publicado: (2020)

Gender Differences and Immunotherapy Outcome in Advanced Lung Cancer
por: Vavalà, Tiziana, et al.
Publicado: (2021)

Advances in Lung Cancer Imaging and Therapy
por: Lopci, Egesta, et al.
Publicado: (2021)

Completion Pneumonectomy for Non-Small-Cell Lung Cancer: Does Induction Treatment Influence Postoperative Outcomes?
por: Galetta, Domenico, et al.
Publicado: (2022)

Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight
por: Cortes-Dericks, Lourdes, et al.
Publicado: (2022)

Targeted Therapies Development in the Treatment of Advanced Nonsmall Cell Lung Cancer
por: Gridelli, Cesare, et al.
Publicado: (2011)

Advances in lung cancer
por: Pacheco, Jose M., et al.
Publicado: (2017)

Rescue Surgery after Immunotherapy/Tyrosine Kinase Inhibitors for Initially Unresectable Lung Cancer
por: Galetta, Domenico, et al.
Publicado: (2022)

Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR Mutations
por: Rossi, Antonio, et al.
Publicado: (2022)

Ovarian Cancer: Advances in Pathophysiology and Therapies
por: Tossetta, Giovanni, et al.
Publicado: (2023)

Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy?
por: Schlachtenberger, Georg, et al.
Publicado: (2023)

Advancing Understanding of Environmental Contributions to Disparities in Lung Cancer
por: Turner, Michelle C.
Publicado: (2022)

Multiple Genetic Alterations as Resistance Mechanism during Second-Line Lorlatinib for Advanced ALK-Rearranged Lung Adenocarcinoma: A Case Report
por: Catino, Annamaria, et al.
Publicado: (2022)

Optimal Therapy for Advanced Non-Small Cell Lung Cancer Without Driver Alterations
por: Pacheco, Jose, et al.
Publicado: (2021)

Advances in Lung Transplantation
por: Tosi, Davide, et al.
Publicado: (2023)

Small pleural holes of the apical parietal pleura: an unknown precursors of cervical lung hernia and association with primary spontaneous pneumothorax
por: Galetta, Domenico, et al.
Publicado: (2023)

Immunotherapy in non-small cell lung cancer: advancements and challenges
por: Zhou, Fei, et al.
Publicado: (2021)

Dendritic Cell and Cancer Therapy
por: Galati, Domenico, et al.
Publicado: (2023)

Advances in cancer therapy: clinical benefit of new cancer drugs
por: Michaeli, Daniel Tobias, et al.
Publicado: (2023)

Update in Lung Cancer Molecular Pathology: Technological Advances and Clinical Practice
por: Graziano, Paolo, et al.
Publicado: (2023)

Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta‐analysis of randomized controlled trials
por: Longo, Vito, et al.
Publicado: (2023)

Advancing Cancer Research: Insights and Innovations in Pathogenesis and Targeted Therapies
por: Wu, Yong, et al.
Publicado: (2023)

Advances in Molecular Pathway-Directed Cancer Systems Imaging and Therapy
por: Yang, David J., et al.
Publicado: (2014)

Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer
por: De Giglio, Andrea, et al.
Publicado: (2022)

Therapy of lung cancer in China: introducing the special collection
por: Gan, Jiadi, et al.
Publicado: (2021)

Current Challenges and Future Advances in Lung Cancer: Genetics, Instrumental Diagnosis and Treatment
por: Vicidomini, Giovanni
Publicado: (2023)

Diagnosis and treatment of non-small cell lung cancer: current advances and challenges
por: Diebels, Ian, et al.
Publicado: (2022)

Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib
por: Montrone, Michele, et al.
Publicado: (2020)

Editorial: Recent Approval of Sotorasib as the First Targeted Therapy for KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC)
por: Parums, Dinah V.
Publicado: (2022)

Photodynamic Therapy: Establishing Its Role in Palliation of Advanced Esophageal Cancer
por: Park, Jong-Jae
Publicado: (2012)

Radical prostatectomy in locally advanced cancer – an indispensable onset of multimodal therapy?
por: Malewski, Wojciech, et al.
Publicado: (2017)

Operable non-small cell lung cancer: induction therapy, adjuvant therapy, or both?
por: Agrafiotis, Apostolos C., et al.
Publicado: (2023)

Advances in Translational Regenerative Therapies
por: Kiwanuka, Harriet, et al.
Publicado: (2023)

Technical Advancement of Radiation Therapy
por: Lee, Tsair-Fwu, et al.
Publicado: (2014)

Advances on the Acupuncture Therapies and Neuroplasticity
por: Liu, Cun-Zhi, et al.
Publicado: (2018)

Advancements in next-generation sequencing for diagnosis and treatment of non-small-cell lung cancer
por: Lu, Ying-Qiang, et al.
Publicado: (2017)

Systemic immune-inflammation index and prognosis of advanced non-small cell lung cancer
por: Alifano, Marco
Publicado: (2020)

Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Cisplatin or carboplatin for advanced non-small cell lung cancer: does it really matter?
por: Kesireddy, Meghana, et al.
Publicado: (2021)

Therapy option for early-stage lung cancer in nonsurgical patients
por: Safi, Seyer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8qbvl9u1mcpm5icm9oadebtru1